News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199,407 Results
Type
Article (9634)
Company Profile (35)
Press Release (189738)
Section
Business (67556)
Career Advice (318)
Deals (16508)
Drug Delivery (26)
Drug Development (17752)
Employer Resources (44)
FDA (2523)
Job Trends (5172)
News (102675)
Policy (6081)
Tag
2024 BioCapital Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 BioForest Digital (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
Academia (723)
Adcomms (1)
Allergies (14)
Alliances (11294)
ALS (29)
Alzheimer's disease (226)
Antibody-drug conjugate (ADC) (29)
Approvals (2535)
Artificial intelligence (74)
Autoimmune disease (5)
Automation (1)
Bankruptcy (156)
Best Places to Work (3831)
BIOSECURE Act (6)
Biosimilars (25)
Biotechnology (34)
Bladder cancer (16)
Brain cancer (6)
Breast cancer (48)
Cancer (522)
Cardiovascular disease (55)
Career advice (284)
Career pathing (7)
CAR-T (44)
Cell therapy (135)
Cervical cancer (4)
Clinical research (14779)
Collaboration (184)
Compensation (74)
Complete response letters (3)
COVID-19 (521)
CRISPR (13)
C-suite (83)
Cystic fibrosis (18)
Data (591)
Denatured (9)
Depression (9)
Diabetes (73)
Diagnostics (1971)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (31)
Drug pricing (22)
Drug shortages (7)
Duchenne muscular dystrophy (21)
Earnings (33363)
Editorial (20)
Employer branding (11)
Employer resources (38)
Events (32558)
Executive appointments (270)
FDA (2802)
Featured Employer (10)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (456)
Gene editing (33)
Generative AI (9)
Gene therapy (105)
GLP-1 (209)
Government (671)
Guidances (26)
Healthcare (5699)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (41)
Indications (5)
Infectious disease (547)
Inflammatory bowel disease (27)
Inflation Reduction Act (5)
Influenza (8)
Intellectual property (31)
Interviews (33)
IPO (9370)
IRA (12)
Job creations (1421)
Job search strategy (258)
Kidney cancer (3)
Labor market (13)
Layoffs (168)
Leadership (3)
Legal (1377)
Liver cancer (25)
Lung cancer (65)
Lymphoma (31)
Machine learning (1)
Management (10)
Manufacturing (100)
MASH (33)
Medical device (4314)
Medtech (4314)
Mergers & acquisitions (7485)
Metabolic disorders (229)
Multiple sclerosis (15)
NASH (8)
Neurodegenerative disease (20)
Neuropsychiatric disorders (6)
Neuroscience (349)
NextGen: Class of 2025 (2150)
Non-profit (1144)
Northern California (1007)
Now hiring (13)
Obesity (123)
Opinion (72)
Ovarian cancer (13)
Pain (22)
Pancreatic cancer (34)
Parkinson's disease (29)
Partnered (5)
Patents (63)
Patient recruitment (29)
Peanut (9)
People (18470)
Pharmaceutical (13)
Pharmacy benefit managers (3)
Phase I (4638)
Phase II (6714)
Phase III (4922)
Pipeline (615)
Podcasts (21)
Policy (30)
Postmarket research (414)
Preclinical (1784)
Press Release (10)
Prostate cancer (37)
Psychedelics (6)
Radiopharmaceuticals (93)
Rare diseases (97)
Real estate (2225)
Recruiting (17)
Regulatory (4427)
Reports (12)
Research institute (631)
Resumes & cover letters (41)
RSV (4)
Schizophrenia (21)
Series A (94)
Series B (64)
Service/supplier (1)
Sickle cell disease (13)
Southern California (806)
Special edition (4)
Spinal muscular atrophy (25)
Sponsored (6)
Startups (2350)
State (1)
Stomach cancer (1)
Supply chain (13)
The Weekly (12)
United States (7607)
Vaccines (116)
Venture capitalists (35)
Webinars (6)
Weight loss (86)
Women's health (16)
Worklife (2)
Date
Last 7 days (216)
Last 30 days (923)
Last 365 days (12139)
2025 (2755)
2024 (12815)
2023 (14281)
2022 (16152)
2021 (17458)
2020 (17251)
2019 (14338)
2018 (10467)
2017 (9729)
2016 (8463)
2015 (11134)
2014 (8203)
2013 (6021)
2012 (6601)
2011 (7238)
2010 (6484)
Location
Africa (194)
Alabama (11)
Alaska (2)
Arizona (47)
Arkansas (3)
Asia (11789)
Australia (1865)
California (2196)
Canada (775)
China (107)
Colorado (91)
Connecticut (127)
Delaware (24)
Europe (22456)
Florida (295)
Georgia (65)
Hawaii (1)
Idaho (29)
Illinois (115)
India (7)
Indiana (85)
Iowa (3)
Japan (29)
Kansas (54)
Kentucky (2)
Louisiana (6)
Maine (19)
Maryland (193)
Massachusetts (1278)
Michigan (123)
Minnesota (118)
Mississippi (1)
Missouri (24)
Montana (5)
Nebraska (5)
Nevada (28)
New Hampshire (21)
New Jersey (578)
New Mexico (5)
New York (694)
North Carolina (320)
North Dakota (1)
Northern California (1007)
Ohio (40)
Oklahoma (14)
Oregon (6)
Pennsylvania (462)
Puerto Rico (2)
Rhode Island (12)
South America (442)
South Carolina (4)
Southern California (806)
Tennessee (23)
Texas (348)
Utah (147)
Virginia (66)
Washington D.C. (13)
Washington State (183)
West Virginia (2)
Wisconsin (8)
199,407 Results for "bay city capital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Gilead Sciences CEO on Company’s Evolution and Commitment to the Bay Area
Today the Foster City-based company is the second-largest biotech employer in the Bay Area.
March 5, 2024
·
1 min read
Mergers & acquisitions
Acelyrin Adopts Poison Pill to Ward Off Tang Capital Buy
The move by Acelyrin’s board comes as the venture capital firm has taken larger and larger stakes in the company in an attempt to disrupt a merger with Alumis.
March 13, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
February 14, 2025
·
1 min read
Press Releases
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day
February 14, 2025
·
2 min read
Genetown
DNB//Back Bay Announces Dates for the Nordic-American Healthcare Conference 2025
DNB Markets (“DNB”) and Back Bay Life Science Advisors (“Back Bay”), acting through the DNB//Back Bay Healthcare Partnership are pleased to announce the dates for our highly anticipated 9th annual Nordic-American Healthcare Conference (NAHC).
April 29, 2024
·
2 min read
Press Releases
AMGEN TO PRESENT AT CITI’S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
February 17, 2025
·
1 min read
Press Releases
City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
March 20, 2025
·
4 min read
Press Releases
Y-mAbs to Participate at Citi’s 2024 Global Healthcare Conference
November 27, 2024
·
5 min read
Business
BIO24 Kicks Off in San Diego as City’s Biotech Hub Gets Hit with Jobs Downturn
While San Diego remains a top biotech hub behind Boston and San Francisco, the city—which hosts this week’s BIO International Convention—has seen employment drop amid economic headwinds.
June 3, 2024
·
5 min read
·
Tyler Patchen
Press Releases
Genmab to Present at Citi’s Global Healthcare Conference
November 25, 2024
·
3 min read
1 of 19,941
Next
